As shown by Märklin et al. (26), NFAT loss leads to an RS phenotype in the CLL mouse model with loss of the cell cycle inhibitors CDKN2A-p14 and TP53 and the activation of AKT. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.